Skip to content
Home/Companies/ClimateTech/Epoch Biodesign

Epoch Biodesign

ClimateTech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Epoch Biodesign?

Epoch Biodesign is a British ClimateTech company, currently owned by Kompas Vc since 2026 and 4 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Mundi Ventures
Most recent investor
Mundi Ventures
Kembara Fund · 2026 · Growth
5 ownership periods · full history below

Key facts

HQUK
SectorClimateTech
Key takeaways
  • ·Co-held by Amadeus Capital Partners, Alma Mundi Ventures, Extantia Capital, Mundi Ventures and Kompas Vc since 2022.
  • ·5 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Co-invest · 4 holders · 2022 · present
Amadeus Capital Partners
2022 · present(4yr) · Amadeus V Technology Fund · 2021 · VC
Alma Mundi Ventures
2023 · present(3yr) · Alma Mundi Fund II · 2020 · VC
Mundi Ventures
2025 · present(1yr) · Kembara Fund · 2026 · Growth
Extantia Capital
2025 · present(1yr) · Extantia Flagship · 2020 · VC
Kompas Vc
Kompas VcActive
2026 · present(<1yr) · Kompas Fund II · 2025 · VC

More from Kembara Fund

Other portfolio companies in the same fund.

Questions

Who owns Epoch Biodesign?

Epoch Biodesign is currently owned by Kompas Vc, Extantia Capital and 3 others, through Kembara Fund, since 2026.

When did Kompas Vc and 4 others acquire Epoch Biodesign?

Kompas Vc and 4 others acquired Epoch Biodesign in 2026.

Who has owned Epoch Biodesign over time?

Epoch Biodesign has been through 5 private-equity ownership periods: Amadeus Capital Partners · via Amadeus V Technology Fund · since 2022; Alma Mundi Ventures · via Alma Mundi Fund II · since 2023; Extantia Capital · via Extantia Flagship · since 2025; Mundi Ventures · via Kembara Fund · since 2025; Kompas Vc · via Kompas Fund II · since 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue